|
« First |
Prev |
|
1 |
2 |
3 |
4 |
|
Next |
Last » |

 Symbol
|

 Gene
|

 Chr
|
 Band
|

 Transcripts
|

 Variants
|

 Unique variants
|

 Last updated
|
 Study Type
|
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
10 |
q23.31 |
1 |
1 |
1 |
2015-09-03 |
Variation |
ADCY2 |
adenylate cyclase 2 |
5 |
p15.31 |
1 |
0 |
0 |
2017-11-02 |
Expression |
AHR |
aryl hydrocarbon receptor |
7 |
p15 |
1 |
1 |
1 |
2015-09-03 |
Variation |
ANKRD12 |
ankyrin repeat domain 12 |
18 |
p11.22 |
1 |
0 |
0 |
2017-11-02 |
Expression |
APBA2 |
amyloid beta precursor protein binding family A member 2 |
15 |
q13.1 |
1 |
0 |
0 |
2017-11-02 |
Expression |
APEX1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
14 |
q11.2 |
1 |
1 |
1 |
2015-09-03 |
Variation |
APOD |
apolipoprotein D |
3 |
q29 |
1 |
0 |
0 |
2015-09-03 |
Expression |
AQP3 |
aquaporin 3 (Gill blood group) |
9 |
p13 |
1 |
0 |
0 |
2015-09-03 |
Expression |
ARID5B |
AT-rich interaction domain 5B |
10 |
q21.2 |
1 |
1 |
1 |
2017-10-29 |
Variation |
ARNT2 |
aryl hydrocarbon receptor nuclear translocator 2 |
15 |
q25.1 |
1 |
0 |
0 |
2017-11-02 |
Expression |
ARNTL |
aryl hydrocarbon receptor nuclear translocator like |
11 |
p15.3 |
1 |
0 |
0 |
2017-11-02 |
Expression |
ARSJ |
arylsulfatase family member J |
4 |
q26 |
1 |
0 |
0 |
2017-11-02 |
Expression |
ATP6V1G1 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 |
9 |
q33.1 |
1 |
0 |
0 |
2015-09-03 |
Expression |
ATXN2 |
ataxin 2 |
12 |
q23-q24.1 |
1 |
1 |
1 |
2015-09-03 |
Variation |
AUTS2 |
autism susceptibility candidate 2 |
7 |
q11.22 |
1 |
1 |
1 |
2015-09-03 |
Variation |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
6 |
q15 |
1 |
2 |
2 |
2015-09-03 |
Variation |
BCAN |
brevican |
1 |
q31 |
1 |
0 |
0 |
2015-09-03 |
Expression |
BCHE |
butyrylcholinesterase |
3 |
q26.1-q26.2 |
1 |
2 |
2 |
2015-09-03 |
Both |
BCL2 |
B-cell CLL/lymphoma 2 |
18 |
q21.3 |
1 |
0 |
0 |
2015-09-03 |
Expression |
BCL2L12 |
BCL2 like 12 |
19 |
q13.33 |
1 |
1 |
1 |
2017-10-29 |
Variation |
BHLHE41 |
basic helix-loop-helix family member e41 |
12 |
p12.1 |
1 |
0 |
0 |
2017-11-02 |
Expression |
BLOC1S5-TXNDC5 |
BLOC1S5-TXNDC5 readthrough (NMD candidate) |
6 |
p24.3 |
1 |
3 |
3 |
2015-09-03 |
Variation |
BLOC1S6 |
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
15 |
q21.1 |
1 |
0 |
0 |
2015-09-03 |
Expression |
BMP6 |
bone morphogenetic protein 6 |
6 |
p24-p23 |
1 |
1 |
1 |
2015-09-03 |
Variation |
C12orf10 |
chromosome 12 open reading frame 10 |
12 |
q13.13 |
1 |
1 |
1 |
2015-09-03 |
Both |
C1QTNF6 |
C1q and tumor necrosis factor related protein 6 |
22 |
q13.1 |
1 |
1 |
1 |
2015-09-03 |
Variation |
C9orf3 |
chromosome 9 open reading frame 3 |
9 |
q22 |
1 |
1 |
1 |
2015-09-03 |
Variation |
CA14 |
carbonic anhydrase XIV |
1 |
q21 |
1 |
0 |
0 |
2015-09-03 |
Expression |
CALR |
calreticulin |
19 |
p13.3-p13.2 |
1 |
0 |
0 |
2015-09-03 |
Expression |
CAPN3 |
calpain 3 |
15 |
q15.1 |
1 |
0 |
0 |
2015-09-03 |
Expression |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
10 |
q25 |
1 |
3 |
3 |
2015-09-03 |
Variation |
CAT |
catalase |
11 |
p13 |
1 |
2 |
2 |
2015-09-03 |
Both |
CAVIN1 |
caveolae associated protein 1 |
17 |
q21.31 |
0 |
0 |
0 |
2017-11-02 |
Expression |
CD46 |
CD46 molecule, complement regulatory protein |
1 |
q32 |
1 |
0 |
0 |
2015-09-03 |
Expression |
CD55 |
CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
1 |
q32 |
1 |
0 |
0 |
2015-09-03 |
Expression |
CDH1 |
cadherin 1, type 1 |
16 |
q22.1 |
1 |
1 |
1 |
2015-09-03 |
Variation |
CDH2 |
cadherin 2 |
18 |
q12.1 |
1 |
0 |
0 |
2017-11-02 |
Expression |
CDH3 |
cadherin 3 |
16 |
q22.1 |
1 |
0 |
0 |
2017-11-02 |
Expression |
CDK5RAP1 |
CDK5 regulatory subunit associated protein 1 |
20 |
q11.21 |
1 |
2 |
2 |
2015-09-03 |
Variation |
CLEC11A |
C-type lectin domain family 11, member A |
19 |
q13.3 |
1 |
1 |
1 |
2015-09-03 |
Variation |
CLEC2B |
C-type lectin domain family 2, member B |
12 |
p13-p12 |
1 |
0 |
0 |
2015-09-03 |
Expression |
CLEC3B |
C-type lectin domain family 3 member B |
3 |
p21.31 |
1 |
0 |
0 |
2017-11-02 |
Expression |
CLOCK |
clock circadian regulator |
4 |
q12 |
1 |
0 |
0 |
2017-11-02 |
Expression |
CLU |
clusterin |
8 |
p21-p12 |
1 |
0 |
0 |
2015-09-03 |
Expression |
COMT |
catechol-O-methyltransferase |
22 |
q11.21 |
1 |
1 |
1 |
2015-09-03 |
Variation |
COX7C |
cytochrome c oxidase subunit VIIc |
5 |
q14 |
1 |
0 |
0 |
2015-09-03 |
Expression |
CPS1 |
carbamoyl-phosphate synthase 1, mitochondrial |
2 |
p |
1 |
0 |
0 |
2015-09-03 |
Expression |
CPVL |
carboxypeptidase, vitellogenic like |
7 |
p14.3 |
1 |
1 |
1 |
2017-10-29 |
Variation |
CRYM |
crystallin mu |
16 |
p12.2 |
1 |
0 |
0 |
2017-11-02 |
Expression |
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4 |
2 |
q33 |
1 |
1 |
1 |
2015-09-03 |
Variation |
CXCL10 |
C-X-C motif chemokine ligand 10 |
4 |
q21.1 |
1 |
0 |
0 |
2017-11-02 |
Expression |
CXCL2 |
C-X-C motif chemokine ligand 2 |
4 |
q13.3 |
1 |
0 |
0 |
2017-11-02 |
Expression |
CXCL9 |
C-X-C motif chemokine ligand 9 |
4 |
q21.1 |
1 |
0 |
0 |
2017-11-02 |
Expression |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
2 |
p22.2 |
1 |
0 |
0 |
2017-11-02 |
Expression |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
10 |
q24.1 |
1 |
1 |
1 |
2015-09-03 |
Variation |
CYP3A5 |
cytochrome P450 family 3 subfamily A member 5 |
7 |
q22.1 |
1 |
0 |
0 |
2017-11-02 |
Expression |
DCT |
dopachrome tautomerase |
13 |
q32 |
1 |
0 |
0 |
2015-09-03 |
Expression |
DDC |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
7 |
p12.1 |
1 |
0 |
0 |
2015-09-03 |
Expression |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
6 |
p21.33 |
1 |
2 |
2 |
2015-09-03 |
Both |
DEF8 |
differentially expressed in FDCP 8 homolog |
16 |
q24.3 |
1 |
1 |
1 |
2017-10-29 |
Variation |
DEFB103A |
defensin, beta 103A |
8 |
p23.1 |
1 |
0 |
0 |
2015-09-03 |
Expression |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
10 |
q11.2 |
1 |
0 |
0 |
2015-09-03 |
Expression |
DNAH5 |
dynein, axonemal, heavy chain 5 |
5 |
p15.2 |
1 |
1 |
1 |
2015-09-03 |
Variation |
DRC3 |
dynein regulatory complex subunit 3 |
17 |
p11.2 |
0 |
0 |
0 |
2017-11-02 |
Expression |
DRD1 |
dopamine receptor D1 |
5 |
q34-q35 |
1 |
0 |
0 |
2015-09-03 |
Expression |
DRD3 |
dopamine receptor D3 |
3 |
q13.3 |
1 |
0 |
0 |
2015-09-03 |
Expression |
DRD4 |
dopamine receptor D4 |
11 |
p15.5 |
1 |
0 |
0 |
2015-09-03 |
Expression |
DUSP2 |
dual specificity phosphatase 2 |
2 |
q11.2 |
1 |
0 |
0 |
2017-11-02 |
Expression |
DUSP8 |
dual specificity phosphatase 8 |
11 |
p15.5 |
1 |
0 |
0 |
2017-11-02 |
Expression |
DVL1 |
dishevelled segment polarity protein 1 |
1 |
p36.33 |
1 |
0 |
0 |
2017-11-02 |
Expression |
EDN1 |
endothelin 1 |
6 |
p24.1 |
1 |
0 |
0 |
2015-09-03 |
Expression |
EDNRB |
endothelin receptor type B |
13 |
q22 |
1 |
0 |
0 |
2015-09-03 |
Expression |
EREG |
epiregulin |
4 |
q21.21 |
1 |
0 |
0 |
2015-09-03 |
Expression |
ERRFI1 |
ERBB receptor feedback inhibitor 1 |
1 |
p36.23 |
1 |
0 |
0 |
2015-09-03 |
Expression |
ESR1 |
estrogen receptor 1 |
6 |
q24-q27 |
1 |
1 |
1 |
2015-09-03 |
Variation |
F2RL1 |
coagulation factor II (thrombin) receptor-like 1 |
5 |
q13 |
1 |
0 |
0 |
2015-09-03 |
Expression |
FAM111B |
family with sequence similarity 111, member B |
11 |
q12.1 |
1 |
0 |
0 |
2015-09-03 |
Expression |
FANCA |
Fanconi anemia, complementation group A |
16 |
q24.3 |
1 |
1 |
1 |
2015-09-03 |
Variation |
FARP2 |
FERM, ARH/RhoGEF and pleckstrin domain protein 2 |
2 |
q37.3 |
1 |
1 |
1 |
2017-10-29 |
Variation |
FBN2 |
fibrillin 2 |
5 |
q23.3 |
1 |
0 |
0 |
2017-11-02 |
Expression |
FBXO11 |
F-box protein 11 |
2 |
p16.3 |
1 |
0 |
0 |
2015-09-03 |
Expression |
FGF2 |
fibroblast growth factor 2 (basic) |
4 |
q26 |
1 |
0 |
0 |
2015-09-03 |
Expression |
FGFR2 |
fibroblast growth factor receptor 2 |
10 |
q26.13 |
1 |
0 |
0 |
2017-11-02 |
Expression |
FOLR3 |
folate receptor 3 |
11 |
q13.4 |
1 |
0 |
0 |
2017-11-02 |
Expression |
FOXO3 |
forkhead box O3 |
6 |
q21 |
1 |
2 |
2 |
2015-09-03 |
Variation |
FOXP1 |
forkhead box P1 |
3 |
p14.1 |
1 |
2 |
2 |
2015-09-03 |
Variation |
FOXP3 |
forkhead box P3 |
X |
p11.23 |
1 |
3 |
3 |
2015-09-03 |
Both |
FURIN |
furin (paired basic amino acid cleaving enzyme) |
15 |
q26.1 |
1 |
0 |
0 |
2015-09-03 |
Expression |
GAGE1 |
G antigen 1 |
X |
p11.23 |
1 |
1 |
1 |
2015-09-03 |
Variation |
GAGE10 |
G antigen 10 |
X |
p11.23 |
1 |
3 |
3 |
2015-09-03 |
Variation |
GATA3 |
GATA binding protein 3 |
10 |
p15 |
1 |
0 |
0 |
2015-09-03 |
Expression |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
6 |
p12 |
1 |
0 |
0 |
2015-09-03 |
Expression |
GCLM |
glutamate-cysteine ligase, modifier subunit |
1 |
p21 |
1 |
0 |
0 |
2015-09-03 |
Expression |
GDF5 |
growth differentiation factor 5 |
20 |
q11.22 |
1 |
0 |
0 |
2017-11-02 |
Expression |
GDNF |
glial cell derived neurotrophic factor |
5 |
p13.2 |
1 |
0 |
0 |
2017-11-02 |
Expression |
GMPR |
guanosine monophosphate reductase |
6 |
p23 |
1 |
0 |
0 |
2015-09-03 |
Expression |
GPM6B |
glycoprotein M6B |
X |
p22.2 |
1 |
0 |
0 |
2017-11-02 |
Expression |
GPR143 |
G protein-coupled receptor 143 |
X |
p22.3 |
1 |
0 |
0 |
2015-09-03 |
Expression |
GPX1 |
glutathione peroxidase 1 |
3 |
p21.3 |
1 |
2 |
2 |
2015-09-03 |
Both |
GRID2IP |
Grid2 interacting protein |
7 |
p22.1 |
1 |
0 |
0 |
2017-11-02 |
Expression |
|
« First |
Prev |
|
1 |
2 |
3 |
4 |
|
Next |
Last » |